As demonstrated in Figure 5, E–G, the percentage of both CD8+ T cells and CD8+ granzyme B+ T cells were increased with POLQ knockdown, suggesting increased T cell–effector function in the tumor microenvironment in that setting. The gene discussed is CD8A; the disease is neoplasm.